These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 34726531)

  • 1. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiomics Signature Predicts the Recurrence-Free Survival in Stage I Non-Small Cell Lung Cancer.
    Wang T; Deng J; She Y; Zhang L; Wang B; Ren Y; Wu J; Xie D; Sun X; Chen C
    Ann Thorac Surg; 2020 Jun; 109(6):1741-1749. PubMed ID: 32087134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
    Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
    Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a Comprehensive Model Based on CT Radiomics and Clinical Features for Postoperative Recurrence Risk Prediction in Non-small Cell Lung Cancer.
    Wang P; Luo Z; Luo C; Wang T
    Acad Radiol; 2024 Jun; 31(6):2579-2590. PubMed ID: 38172022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
    Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
    PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.
    Ye G; Wu G; Zhang C; Wang M; Liu H; Song E; Zhuang Y; Li K; Qi Y; Liao Y
    Front Immunol; 2024; 15():1414954. PubMed ID: 38933281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
    Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
    Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
    Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
    Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
    Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non-Small Cell Lung Cancer.
    Takenaka T; Yamazaki K; Miura N; Mori R; Takeo S
    J Thorac Oncol; 2016 Jul; 11(7):1074-80. PubMed ID: 26899756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study.
    Chen QL; Li MM; Xue T; Peng H; Shi J; Li YY; Duan SF; Feng F
    Clin Radiol; 2023 May; 78(5):e359-e367. PubMed ID: 36858926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Habitat radiomics and deep learning fusion nomogram to predict EGFR mutation status in stage I non-small cell lung cancer: a multicenter study.
    Wu J; Meng H; Zhou L; Wang M; Jin S; Ji H; Liu B; Jin P; Du C
    Sci Rep; 2024 Jul; 14(1):15877. PubMed ID: 38982267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Utility of a CT-based AI Prognostic Model for Segmentectomy in Non-Small Cell Lung Cancer.
    Na KJ; Kim YT; Goo JM; Kim H
    Radiology; 2024 Apr; 311(1):e231793. PubMed ID: 38625008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.